AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 94 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $173,000 | -46.8% | 76,324 | -20.5% | 0.02% | -48.6% |
| Q1 2021 | $325,000 | +550.0% | 96,016 | +438.4% | 0.04% | +362.5% |
| Q4 2020 | $50,000 | -74.9% | 17,833 | -77.5% | 0.01% | -75.0% |
| Q3 2020 | $199,000 | +40.1% | 79,240 | +321.8% | 0.03% | +14.3% |
| Q1 2020 | $142,000 | -34.0% | 18,787 | -51.5% | 0.03% | -24.3% |
| Q4 2018 | $215,000 | +121.6% | 38,767 | +252.8% | 0.04% | +184.6% |
| Q3 2018 | $97,000 | -73.4% | 10,989 | -69.9% | 0.01% | -76.4% |
| Q2 2018 | $365,000 | +50.2% | 36,534 | +43.0% | 0.06% | +52.8% |
| Q1 2018 | $243,000 | -41.4% | 25,556 | +21.0% | 0.04% | -46.3% |
| Q3 2017 | $415,000 | +174.8% | 21,115 | +45.4% | 0.07% | +63.4% |
| Q4 2016 | $151,000 | +2.7% | 14,518 | -26.0% | 0.04% | +2.5% |
| Q2 2016 | $147,000 | – | 19,629 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $1,471,000 | 1.42% |
| Orchard Capital Management, LLC | 251,826 | $80,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 486,568 | $154,000 | 0.02% |
| Icon Wealth Advisors, LLC | 400,132 | $127 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 7,483,053 | $2,365,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,042,816 | $646,000 | 0.01% |
| WIPFLI FINANCIAL ADVISORS LLC, | 200,000 | $63,000 | 0.00% |
| WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
| James J. Burns & Company, LLC | 25,142 | $8,000 | 0.00% |
| Bayesian Capital Management, LP | 68,600 | $22,000 | 0.00% |